Detalles de la búsqueda
1.
Protective effects of the SGLT2 inhibitor luseogliflozin on pancreatic ß-cells in db/db mice: The earlier and longer, the better.
Diabetes Obes Metab
; 20(10): 2442-2457, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29873444
2.
Anti-hypertensive azelnidipine preserves insulin signaling and glucose uptake against oxidative stress in 3T3-L1 adipocytes.
Endocr J
; 62(8): 741-7, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26073866
3.
Influence of atherosclerosis-related risk factors on serum high-sensitivity C-reactive protein levels in patients with type 2 diabetes: Comparison of their influence in obese and non-obese patients.
J Diabetes Investig
; 7(2): 197-205, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27042271
4.
Seven-year Observational Study on the Association between Glycemic Control and the New Onset of Macroangiopathy in Japanese Subjects with Type 2 Diabetes.
Intern Med
; 55(11): 1419-24, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27250046
5.
Insulin allergy brought out 8 years after starting insulin therapy in a subject with type 1 diabetes mellitus.
Acta Diabetol
; 57(8): 1025-1026, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32078040
6.
Concomitant use of miglitol and mitiglinide as initial combination therapy in type 2 diabetes mellitus.
Diabetes Res Clin Pract
; 101(1): 35-44, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23711593
Resultados
1 -
6
de 6
1
Próxima >
>>